Manhattan Shooting, US-China Talks and Lung-on-a-Chip

In partnership with

Anna's Daybreak News

Just facts, you think for yourself

Tuesday, 5:13 AM

July 29, 2025

Good morning news friend! Step into today’s defining moments and see how they shape the future. 📰🌟

Click here to read the poll results and comments from our previous edition. Over 4,343 people gave their opinion about the US-EU trade deal, the Walmart stabbing and more!

Can’t see all 6 articles in this email? The Gmail app sometimes crops our emails, click here to view full edition.

Manhattan Shooting

Yesterday, Shane Tamura, 27, opened fire at 345 Park Avenue, Midtown Manhattan, killing four people, including NYPD officer Didarul Islam and a Blackstone executive.

Tamura used an M4 rifle, shot one victim on the 33rd floor, then killed himself. One victim remains critical; four others sustained minor injuries. Tamura had a history of mental illness and drove cross-country days before the attack.

Motive remains unknown. Police responded swiftly. The incident raises concerns about security at prominent workplaces. The investigation is ongoing.

In your view, what is the most important factor to address to prevent future attacks like the Midtown shooting?

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

You’re smart about saving money, like shopping clearance racks, limiting eating out, and choosing affordable streaming services. However, there are still some cost-cutting tips you might not know yet. Once you discover these, you could quickly find extra cash in your pocket.

Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)

Trump Cuts Russia’s Ukraine Truce Deadline to 10-12 Days

President Trump shortened Russia’s Ukraine truce deadline from 50 to 10–12 days, warning of U.S. economic sanctions and possible tariffs if Russia fails to act. The conflict, now 3.5 years old, sees intensified Russian summer offensives despite territorial losses by Ukraine.

Ukrainian President Zelenskiy welcomed tougher sanctions and recent U.S. Patriot missile deliveries. Kremlin officials did not comment immediately; former Russian President Medvedev criticized Trump’s ultimatums, warning of escalation.

Trump plans to pursue penalties without further talks. Meanwhile, Ukraine seeks a Putin-Zelenskiy summit. U.S. lawmakers urge swift sanctions and continued support for Ukraine.

Sources: Bloomberg, Reuters, EuroNews, BBC.

Do you think setting a short deadline (10-12 days) for Russia to agree to a truce is an effective way to pressure them toward peace?

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

Find out why 1M+ professionals read Superhuman AI daily.

In 2 years you will be working for AI

Or an AI will be working for you

Here's how you can future-proof yourself:

  1. Join the Superhuman AI newsletter – read by 1M+ people at top companies

  2. Master AI tools, tutorials, and news in just 3 minutes a day

  3. Become 10X more productive using AI

Join 1,000,000+ pros at companies like Google, Meta, and Amazon that are using AI to get ahead.

Dislike this ads? Click here for an ad-free experience (only $5 per month)

Medicare Part D Premiums Set for Sharp Rise in 2026

Medicare Part D premiums will rise sharply in 2026 due to a 40% cut in federal subsidies, dropping monthly plan subsidies from $15 to $10.

Average premiums, currently around $36, could increase by up to $50 next year, compared to a $35 cap this year. Without subsidies, premiums would be $42–$46.50. The out-of-pocket drug cost cap will increase from $2,000 in 2025 to about $2,100 in 2026.

Insulin users pay no more than $35 monthly. Insurers face greater financial risk as current protections end. Higher premiums may push seniors toward Medicare Advantage plans bundling drug and other coverage.

Given the planned 2026 premium increase for Medicare Part D, do you think seniors will prioritize:

Click to see live results and comment!

Login or Subscribe to participate in polls.

This free version is ad-supported.

While the crowd’s chasing yesterday’s headlines, the real money’s brewing in the shadows. 2025’s megatrends - AI’s takeover, consumer empires doubling down, aerial taxis rewriting travel - are already here.

MarketBeat’s analysts sifted the chaff to deliver these 10 picks… And they could very well be your ticket to profits the masses will miss. Free today, after that, it’s strictly for paid members. Act now or watch from the sidelines later!

Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)

US-China Talks Hint at 90-Day Extension

U.S. and Chinese officials met in Stockholm to discuss extending the current trade truce by 90 days, preventing tariffs from snapping back to prior high levels (up to 145% U.S., 125% China).

Current tariffs are 30% on U.S. goods entering China and 10% on Chinese goods entering the U.S. Talks covered U.S. tech export controls, Chinese oil purchases from Russia and Iran, and fentanyl-related tariffs.

A major breakthrough was not expected; the extension delays an August deadline ahead of a potential Trump-Xi summit in late 2025. The U.S. recently secured a 15% tariff deal with the EU.

Taiwan postponed a U.S. visit to avoid tensions during negotiations.

Do you think the prospect of a Trump-Xi summit will lead to a meaningful long-term trade agreement, or just temporary fixes?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Lung-on-a-Chip

Kyoto University researchers developed a lung-on-chip system using patient-specific iPSC-derived tissues that replicate distinct responses of both proximal airway and distal alveoli to respiratory viruses.

This model overcomes limitations of animal and simple cell models by mimicking human lung complexity, enabling precise study of viral infections and drug testing. The device supports personalized medicine approaches and could expand to other organs and multi-organ interactions.

This innovation enhances early drug screening and virus research, potentially improving treatment of respiratory diseases and pandemic responses.

Are you comfortable with using stem cells derived from patients for research and treatment purposes?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Blazing Gold Shatters Temperature Limits

Researchers superheated gold foil to over 19,000 K—more than 14 times its melting point—without melting. Using 45-femtosecond laser pulses, the gold heated so rapidly that atomic expansion and melting were prevented, keeping the solid state stable for over 2 picoseconds.

X-ray diffraction confirmed the crystal lattice remained intact, even at heating rates above 10^15 K/s. This contradicts the long-held "entropy catastrophe" theory, which predicted solids would melt past three times their melting temperature. The findings suggest solids can remain stable at much higher temperatures if expansion is suppressed rapidly, opening new paths in high-energy-density physics, materials science, planetary physics, and fusion energy research.

Do you think the discovery that gold can remain solid at temperatures 14 times its melting point will fundamentally change our understanding of materials science?

Click to see live results and comment!

Login or Subscribe to participate in polls.

When one sensible man happens upon another, there is a kind of silent recognition, like two clocks that were built by the same master and are bound to keep the same time.

We don’t take shortcuts, chase headlines, or push narratives. We just bring you the news, straight and fair. If you value that, click here to become a paid subscriber—your support makes all the difference.

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

Baked with love,

Anna Eisenberg ❤️

What did you think of today's edition?

Click to see live results and comment!

Login or Subscribe to participate in polls.